Dr. Francisco J. Hernandez-ILizaliturri
Claim this profileRoswell Park Cancer Institute
Studies Cancer
Studies Lymphoma
10 reported clinical trials
25 drugs studied
Area of expertise
1Cancer
Stage IV
CD-19 positive
CD20 positive
2Lymphoma
Stage IV
CD20 positive
Stage III
Affiliated Hospitals
Clinical Trials Francisco J. Hernandez-ILizaliturri is currently running
Tirabrutinib
for Central Nervous System Lymphoma
This trial is testing tirabrutinib alone and with other cancer drugs in patients with PCNSL. It targets those who haven't responded to previous treatments or are newly diagnosed. Tirabrutinib works by blocking a protein that helps cancer cells grow. Tirabrutinib was approved for use in treating primary central nervous system lymphoma.
Recruiting1 award Phase 210 criteria
GM T Cell Therapy Long-Term Follow-Up
for Cancer
This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least one GM T cell infusion will be asked to enroll in this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.
Recruiting1 award Phase 2 & 3
More about Francisco J. Hernandez-ILizaliturri
Clinical Trial Related6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Francisco J. Hernandez-ILizaliturri has experience with
- Etoposide
- Ibrutinib
- Cyclophosphamide
- Obinutuzumab
- Prednisone
- EGFRt/19-28z/IL-12 CAR T Cells
Breakdown of trials Francisco J. Hernandez-ILizaliturri has run
Cancer
Lymphoma
B-Cell Lymphoma
Chronic Lymphocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Francisco J. Hernandez-ILizaliturri specialize in?
Francisco J. Hernandez-ILizaliturri focuses on Cancer and Lymphoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are CD-19 positive.
Is Francisco J. Hernandez-ILizaliturri currently recruiting for clinical trials?
Yes, Francisco J. Hernandez-ILizaliturri is currently recruiting for 3 clinical trials in Buffalo New York. If you're interested in participating, you should apply.
Are there any treatments that Francisco J. Hernandez-ILizaliturri has studied deeply?
Yes, Francisco J. Hernandez-ILizaliturri has studied treatments such as Etoposide, Ibrutinib, Cyclophosphamide.
What is the best way to schedule an appointment with Francisco J. Hernandez-ILizaliturri?
Apply for one of the trials that Francisco J. Hernandez-ILizaliturri is conducting.
What is the office address of Francisco J. Hernandez-ILizaliturri?
The office of Francisco J. Hernandez-ILizaliturri is located at: Roswell Park Cancer Institute, Buffalo, New York 14263 United States. This is the address for their practice at the Roswell Park Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.